/i.s3.glbimg.com/v1/AUTH_59edd422c0c84a879bd37670ae4f538a/internal_photos/bs/2021/H/w/YbA657S3aYVfC0P9wboQ/g1-favicon.png){kind=small}
/i.s3.glbimg.com/v1/AUTH_da025474c0c44edd99332dddb09cabe8/internal_photos/bs/2023/1/X/nkkB7tSdirnIUbGhakCQ/favicon-o-globo.png){kind=small}
Overview
- Health ministry sets a nationwide Day D for prevention on November 8 as part of the new campaign against dengue, zika and chikungunya.
- The ministry says Anvisa is in final checks and expects to approve Butantan’s single‑dose vaccine by late 2025, with up to 40 million doses planned for 2026 via WuXi Biologics.
- Federal funding of roughly R$184 million will expand vector‑control technologies, including Wolbachia mosquito releases and the rollout of Larvicide Dissemination Stations.
- Official data show 1,611,826 probable dengue cases and 1,688 deaths in 2025 to date, about 75% and 72% lower than the same period in 2024, while around 30% of municipalities are on alert.
- A new seven‑year analysis from the TIDES study reports sustained protection from Qdenga, reinforcing current vaccination of 10–14‑year‑olds as strategies evolve.